Drug wholesalers have been banned from exporting HRT abroad in an attempt to tackle worsening shortages in the UK.
The Government last night imposed a blanket ban on the export of 27 types of medication, including all HRT drugs, epipens and some blood-thinning pills.
It is the first time that such an extreme measure has been taken, and follows warnings that pharmacists are ‘barely coping’ due to shortages in every category of medicine.
Health Secretary Matt Hancock yesterday thanked the Daily Mail for revealing the extent of the HRT crisis as he announced the unprecedented Government intervention.
Drug wholesalers have been banned from exporting HRT abroad to tackle drug shortages. Pictured, Fiona Russell, 51, who burst into tears of relief when her GP finally managed to track down some HRT drugs that she had been taking for two-and-a-half year
Mr Hancock said: ‘The new measures we’re introducing today will help us ensure patients get the medicines they need and I want to thank the Daily Mail for campaigning on this issue.
‘I know how distressing medicine shortages can be for those who rely on drugs like HRT and I’m determined to do everything I can so patients can always access safe and effective treatments through the NHS. These measures will help us deal with any shortages.
‘We have well established processes to manage supply issues but we are always exploring new ways to help mitigate the risk of these issues affecting UK patients.
‘I know that HRT in particular has caused concern for a lot of patients who are going through the menopause. I want to assure them that we will do all we can to help resolve this issue as quickly as possible.’
The new measures means that drugs which are in short supply will have to be given to patients in the UK, rather than being sold abroad for higher profit.
The rule applies to 19 types of hormone replacement therapy (HRT).
It covers a further eight medicines, including all epipens, Hepatitis B vaccines, the contraceptive pill Levonorgestrel and Rivaroxaban, which prevents blood clots.
Currently pharmaceutical wholesalers based in Britain are allowed to sell their products abroad and the fall in the value in the pound means wholesalers can get higher prices on the continent.
But now any companies who export HRT or any other restricted drugs face punishment by the medicines watchdog.
The ban comes after the Daily Mail campaigned for action to address the HRT crisis, which is hitting hundreds of thousands of women and forcing some to travel abroad to buy drugs.
HRT is delivered in patches, tablets or gels and provides the oestrogen that the body stops producing during menopause.
Up to one million women in Britain take the medication every year, with around 360,000 prescriptions of HRT dispensed a month.
Mr Edward Morris, Vice President of the Royal College of Obstetricians and Gynaecologists, said: ‘We welcome this new approach to tackling HRT shortages.
‘While the situation appears to be improving we are aware that some women across the UK are still having difficultly accessing HRT products due to these ongoing manufacturing and supply issues.
‘It’s vital to ensure medicine supply chains are closely monitored to prevent this situation from happening again.’
Although HRT has been the worst-affected by recent shortages, a major investigation this week revealed that pharmacists have run out of all 36 major categories of medicines in recent months.
The mass shortages have been caused by a ‘perfect storm’ of manufacturing problems in the global supply chain.
Six in ten pharmacists say they are struggling to get hold of epilepsy medication and experts say the shortages are putting patients’ lives at risk.
The new measures apply to 19 types of hormone replacement therapy (HRT), including Tibolone (brand name Livial)
Levonorgestrel, an emergency contraceptive pill (picture), is one of the 24 drugs that’s been banned from being exported
Clare Pelham, Chief Executive at Epilepsy Society said: ‘People with epilepsy are totally dependent on getting the right medication, at the right dose, to control their seizures.
‘It is absolutely unacceptable that they do not know, from one prescription to the next, whether their pharmacist will be able to access their medicines.
‘Our helpline is inundated with calls from people who are having to traipse around different chemists in the hopes of finding someone with a stock of the drugs they need.’
Ms Pelham added: ‘Every day we are talking with worried parents who are anxious that their sons and daughters will not be able to get the medicines they need.
‘Without the right medication, at the right dose, seizures can increase in both severity and frequency and for those who are most vulnerable, this is a huge cause of concern.
‘As we know only too well, seizures are not benign events but can be fatal. We are calling on the Government to urgently commission a review of the medicines supply chain and get this sorted.’
The crisis means thousands of patients are turning up at their pharmacy with a GP prescription, only to be sent home empty handed as their medication is out of stock.
Yesterday a survey of pharmacists by Chemist and Druggist found that three in four are unable to supply a medicine to patients three or more times a day.
Over a third said this happens five or more times a day.
Pharmacists and GPs have warned that the drug shortages are adding to their workload as they are forced to spend hours looking for alternative medication.
Ravi Sharma, from the Royal Pharmaceutical Society, said: ‘Pharmacists are very stressed and having to spend a lot of time chasing up manufacturers and finding medicines. In the past few months things have got very bad.
‘They are spending up to an hour a day trying to source medicines when they should be talking to patients.’
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: ‘Sourcing alternatives in the event of drug shortages can be hugely frustrating and time-consuming for GPs and pharmacists, as well as inconvenient and worrying for patients.’
Dr Rick Greville, Director of Supply Chain at the Association of the British Pharmaceutical Industry, welcomed the export ban.
He said: ‘The decision to take precautionary measures to protect medicines supplies will be very much welcomed by our members.
‘It means that these stockpiles of medicines which companies have built over previous months are better protected and available for use only by the NHS patients for which they were intended.
‘Companies can now work with the Department to identify any problem areas.’